ERBB2 and breast carcinoma: A 5-year analysis showed that patients achieving a total pCR with all groups combined had a longer PFS compared with patients that did not achieve total pCR, thus suggesting that pCR could be an early indicator of long-term outcome in early-stage HER2-positive breast cancer [13].